News
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Aroundtown SA: Release of a capital market information
EQS-News: SNP Completes CEO Transition: Dr. Jens Amail to Take Over as New CEO in January 2023
Chelverton UK Dividend Trust plc: Net Asset Value(s)
ISG Announces 2022 ISG Paragon Awards™ EMEA Finalists
Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced the finalists for the 2022 ISG Paragon Awards™ EMEA, which celebrate
EQS-News: Heidelberg Pharma’s Partner Telix Reports Positive Data on the Pivotal ZIRCON Study
EQS-News: Game on: Goliath Resources reports 98% hit rate with high-grade mineralization at Surebet!
CREALOGIX’ new research suggests investors want support to adopt crypto
EQS-News: Pyramid AG’s faytech Tech Co Ltd. announces Joint Framework Agreement with ICS to produce and supply Non-Touch Control Displays for use in Autonomous Flexible Charging Stations
PMHH Is Pleased to Complete Its Offer for Swedish Match and Become the Owner of 82.59% of the Shares; Extends the Offer Period; and Adjusts the Price for Future Tenders Due to the Scheduled Dividend
Regulatory News:
This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand, or South Africa or in any other jurisdiction where such offer
EQS-Adhoc: Cherry AG: Forecast update for the fiscal year 2022
Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing
Transgene Reports Business Update And Q3 2022 Financial Position
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business
EQS-News: q.beyond confirms preliminary results: revenues grow by 8% in Q3 2022
DKSH Continues Strengthening its Healthcare Own Brands Business With the Acquisition of two Brands From Eisai
Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a) at the American Heart Association (AHA) 2022 Annual Meeting
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through
WISH Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of the world’s largest mobile e-commerce platforms, today announced, as required by Nasdaq Listing Rule 5635(c)(4), the grant of inducement awards
State Street Announces Inaugural $500 Million Bond Issuance Under its Sustainability Bond Framework
State Street Corporation today announced that it has issued $1 billion of senior unsecured bonds, including an inaugural $500 million bond issued under its Sustainability Bond Framework (the
AbCellera to Present at Upcoming Investor Conferences in November
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:
-
Credit Suisse 31st Annual Healthcare Conference on Wednesday
Mannatech is Reinventing Hydration, Introduces Exclusive Blue Water
Global health and wellness brand Mannatech, Incorporated (NASDAQ: MTEX) announces its latest innovation today with the launch of Blue Water, a functional drink for both hydration and immune
EQS-Adhoc: artnet AG: artnet publishes preliminary figures for the third quarter of 2022, adjusts forecast for fiscal year 2022, and expects cash inflow from US grant program
Fuller, Smith & Turner PLC: Transaction in Own Shares